Literature DB >> 36210710

[RHPN2 is highly expressed in osteosarcoma cells to promote cell proliferation and migration and inhibit apoptosis].

Z Liu1, F Fang1, J Li2, G Zhao1, Q Zang2, F Zhang1, J Die1.   

Abstract

OBJECTIVE: To screen for aberrantly expressed genes in osteosarcoma cells and investigate the role of RHPN2 in regulating the proliferation, apoptosis, migration and tumorigenic abilities of osteosarcoma cells.
METHODS: We used GEO2R to analyze the differential gene expression profile between osteosarcoma cells and normal cells in the GSE70414 dataset. RTqPCR and Western blotting were performed to detect RHPN2 expression in osteosarcoma cell lines MG-63, 143B and SAOS2. Two RHPN2-shRNA and a control NC-shRNA were designed to silence the expression of RHPN2 in 143B cells, and CCK8 assay, colony-forming assay, annexin V-FITC/PI staining and scratch assays were carried out to examine the changes in proliferation, apoptosis and migration of the cells. We also established nude mouse models bearing osteosarcoma xenografts derived 143B cells and RHPN2-shRNA-transfected 143B cells, and assessed the effect of RHPN2 silencing on osteosarcoma cell tumorigenesis using HE staining. Kaplan-Meier survival curves were used to analyze the correlation between RHPN2 expression and survival outcomes of patients with osteosarcoma.
RESULTS: RHPN2 expression was significantly upregulated in osteosarcoma cell lines MG-63, 143B and SAOS2 (P < 0.01). Silencing of RHPN2 significantly inhibited the proliferation and migration of 143B cells in vitro, promoted cell apoptosis (P < 0.01), and suppressed tumorigenic capacity of the cells in nude mice. A high expression of RHPN2 was significantly correlated with a poor prognosis of patients with osteosarcoma (P < 0.05).
CONCLUSION: RHPN2 is highly expressed in osteosarcoma cells to promote cell proliferation and migration and inhibits cell apoptosis. A high expression of RHPN2 is associated with a poorer prognosis of the patients with osteosarcoma.

Entities:  

Keywords:  RHPN2; bioinformatics analysis; osteosarcoma; prognosis; proliferation

Mesh:

Substances:

Year:  2022        PMID: 36210710      PMCID: PMC9550552          DOI: 10.12122/j.issn.1673-4254.2022.09.13

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  30 in total

Review 1.  Bone microenvironment signals in osteosarcoma development.

Authors:  Arantzazu Alfranca; Lucia Martinez-Cruzado; Juan Tornin; Ander Abarrategi; Teresa Amaral; Enrique de Alava; Pablo Menendez; Javier Garcia-Castro; Rene Rodriguez
Journal:  Cell Mol Life Sci       Date:  2015-05-03       Impact factor: 9.261

2.  Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.

Authors:  Md Habibur Rahman; Humayan Kabir Rana; Silong Peng; Xiyuan Hu; Chen Chen; Julian M W Quinn; Mohammad Ali Moni
Journal:  Brief Bioinform       Date:  2021-01-06       Impact factor: 11.622

Review 3.  Osteosarcoma, Chondrosarcoma, and Chordoma.

Authors:  Jeremy S Whelan; Lara E Davis
Journal:  J Clin Oncol       Date:  2017-12-08       Impact factor: 44.544

4.  RHPN2 Promotes Malignant Cell Behaviours in Ovarian Cancer by Activating STAT3 Signalling.

Authors:  Fengsheng Yu; Pingping Qiao; Guangjie Yin; Yewu Sun; Xiao Yu; Xin Sun; Yijing Chu; Yankui Wang
Journal:  Onco Targets Ther       Date:  2020-11-10       Impact factor: 4.147

5.  Up-regulated isocitrate dehydrogenase 1 suppresses proliferation, migration and invasion in osteosarcoma: in vitro and in vivo.

Authors:  Xiang Hu; Yang Liu; Chunxia Qin; Zhenyu Pan; Jun Luo; Aixi Yu; Zhen Cheng
Journal:  Cancer Lett       Date:  2013-12-22       Impact factor: 8.679

6.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

7.  LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p.

Authors:  Honghai Song; Jiaming Liu; Xin Wu; Yang Zhou; Xuanyin Chen; Jiangwei Chen; Keyu Deng; Chunxia Mao; Shanhu Huang; Zhili Liu
Journal:  Aging (Albany NY)       Date:  2019-11-13       Impact factor: 5.682

8.  Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2.

Authors:  Shuangjian Jiang; Chengqiang Mo; Shengjie Guo; Jintao Zhuang; Bin Huang; Xiaopeng Mao
Journal:  J Exp Clin Cancer Res       Date:  2019-12-17

9.  Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma.

Authors:  Wentao Bo; Xielin Feng; Xiaoli Tang
Journal:  Oncol Lett       Date:  2020-11-25       Impact factor: 2.967

Review 10.  Osteosarcoma and Metastasis.

Authors:  Gaohong Sheng; Yuan Gao; Yong Yang; Hua Wu
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.